Our Projects
Three teams, three projects
INOvA
The main focus of INOvA is to establish Innovative Novel Ovarian Cancer Treatment Approaches. We aim to establish our own “cancer immunogram” with specific parameters, to identify interesting biomarker/immunotherapeutic targets, to be able to stratify patients based on the immunogram scoring system and to propose treatment options accordingly. Read more…
PDAC
The major problem of PDAC is the current lack of active drugs/cell-based therapies that are able to significantly increase patient survival. Our aim is to develop PDAC models that properly represent tumour-intrinsic heterogeneity as well as tumour microenvironmental factors and to improve therapeutic efficacy in PDAC. Read more…
PreLIM
PreLIM focuses on the development of novel preclinical models of leukemias and lymphomas in the development of novel targeted and immune therapies, and exploration of microenvironmental factors critical to disease development and emergence of resistant clones. Read more…
precoslab.com 